The role of immune factors in the development of preterm birth

Cover Page

Cite item

Full Text

Abstract

Preterm birth (PB) carries a high risk of developing neuropsychological development disorders, cognitive and somatic problems in the child. The maternal immune system plays a critical role in maintaining a physiological pregnancy. However, specific mechanisms and disorders of pregnancy development have been little studied. There is a lack of research on the role of immune competent cell (ICC) activation in preterm labor leading to uterine contractility. Understanding the importance of immune system factors in the formation of preterm birth may allow the development of strategies to prolong pregnancy and, thus, lead to improved perinatal outcomes. The purpose of the work is to study the role of immune factors in the development of preterm birth. Seventy pregnant women in the third trimester with recurrent miscarriage (RPL) and 25 healthy pregnant women (control group) were examined. Observed pregnant women with RPL were divided into two groups: Group I – patients who gave birth prematurely (n = 30); and Group II – patients who gave birth at term (n = 40). The population and subpopulation composition of peripheral blood lymphocytes was studied by cytofluorimetry using monoclonal antibodies to: CD3, CD4, CD8, CD16, CD19 (JSC "Sorbent", Russia) (FITC), CD11b (Beckman Coulter, USA); CD14, CD25, CD69, CD71, CD28, CD107a, HLA-DR (Beckman Coulter, USA) (PE). To create a database and conduct statistical research, the capabilities of an Excel spreadsheet and application packages (Megastat and Statistica 6.0) were used. When determining statistical significance between the study groups, the Mann-Whitney test was used for independent groups and the Wilcoxon test for dependent groups.

Modulation of the number and functional activity of ICC in patients with RPL had a significant correlation with pregnancy outcome. Inadequate activation of the immune system is a factor that can lead to miscarriage. Termination of pregnancy before term is associated with subpopulation shifts, increased activation potencies of immunocompetent cells compared to full-term birth, which is an important feature of the inflammatory response. The identified immune changes will allow the development of early prevention methods and new approaches to the treatment of this pregnancy complication.

About the authors

M. A. Levkovich

Rostov State Medical University

Author for correspondence.
Email: xlma@mail.ru

PhD, MD (Medicine), Associate Professor, Leading Research Associate, Department of Allergy and Autoimmune Diseases, Research Institute of Obstetrics and Pediatrics

Russian Federation, Rostov-on-Don

I. I. Krukier

Rostov State Medical University

Email: xlma@mail.ru

PhD, MD (Biology), Leading Research Associate, Obstetrics and Gynecology Department, Research Institute of Obstetrics and Pediatrics

Russian Federation, Rostov-on-Don

V. V. Avrutskaya

Rostov State Medical University

Email: xlma@mail.ru

PhD, MD (Medicine), Associate Professor, Professor of the Department of Obstetrics and Gynecology No. 2

Russian Federation, Rostov-on-Don

N. V. Ermolova

Rostov State Medical University

Email: xlma@mail.ru

PhD, MD (Medicine), Associate Professor, Head, Obstetrics and Gynecology Department, Research Institute of Obstetrics and Pediatrics

Russian Federation, Rostov-on-Don

L. V. Kravchenko

Rostov State Medical University

Email: xlma@mail.ru

PhD, MD (Medicine), Leading Research Associate, Department of Pediatrics, Research Institute of Obstetrics and Pediatrics

Russian Federation, Rostov-on-Don

References

  1. Артымук Н.В., Елизарова Н.Н. Факторы риска преждевременного разрыва плодных оболочек у женщин с преждевременными родами в Кемеровской области // Фундаментальная и клиническая медицина, 2016. Т. 1, № 2. С. 6-11. [Artymuk N.V., Elizarova N.N. Risk factors for premature rupture of membranes in women with premature birth in the Kemerovo region. Fundamentalnaya i klinicheskaya meditsina = Fundamental and Clinical Medicine, 2016, Vol. 1, no. 2, pp. 6-11. (In Russ.)]
  2. Левкович М.А., Нефедова Д.Д., Плахотя Т.Г. Иммунологические предикторы невынашивания беременности в I триместре// Журнал акушерства и женских болезней, 2017. Т. 66, № S. С. 38-39. [Levkovich M.A., Nefedova D.D., Plahot T.G. Immunological predictors of miscarriage in the first trimester. Zhurnal akusherstva i zhenskikh bolezney = Journal of Obstetrics and Women’s Diseases, 2017, Vol. 66, no. S, pp. 38-39. (In Russ.)]
  3. Крукиер И.И., Авруцкая В.В., Левкович М.А., Нарежная Е.В., Смолянинов Г.В., Ержданян Л.Л., Никашина А.А. Особенности изменения биорегуляторов и органических кислот в сыворотке крови и амниотической жидкости женщин со спонтанными преждевременными родами // Вестник Российской академии медицинских наук, 2018. Т. 73, № 6. С. 361-367. [Krukier I.I., Avrutskaya V.V., Levkovich M.A., Narezhnaya E.V., Smolyaninov G.V., Erzhdanyan L.L., Nikashina A.A. Features of changes in bioregulators and organic acids in blood serum and amniotic fluid of women with spontaneous premature birth . Vestnik Rossiyskoy akademii meditsinskikh nauk = Bulletin of the Russian Academy of Medical Sciences, 2018, Vol. 73, no. 6, pp.. 361-367. (In Russ.)]
  4. Смирнова А.В., Борзова Н.Ю., Сотникова Н.Ю., Малышкина А.И. Клинико-иммунологические факторы риска очень ранних преждевременных родов // Проблемы репродукции, 2020. Т. 26, № 2. С. 113-119. [Smirnova A.V., Borzova N.Yu., Sotnikova N.Yu., Malyshkina A.I. Clinical and immunological risk factors for very early preterm birth. Problemy reproduktsii = Problems of Reproduction, 2020, Vol. 26, no. 2, pp. 113-119. (In Russ.)]
  5. Yougbaré I., Tai W.-Sh., Zdravic D., Oswald B.E., Lang S. Activated NK cells cause placental dysfunction and miscarriages in fetal alloimmune thrombocytopenia. Nat.Commun., 2017, Vol. 8, no. 1, 224. doi: 10.1038/s41467-017-00269-1.
  6. Zhang J., Shynlova O., SabraS., Bang A., Briollais L., Lye S.J. Immunophenotyping and activation status of maternal peripheral blood leukocytes during pregnancy and labour, both term and preterm. J. Cell. Mol. Med., 2017,Vol. 21, no. 10, pp. 2386-2402.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Figure 1. Indicators of immune status in patients of clinical groups Note. *, value (p < 0.05) when comparing group I and control group; ▲, value (p < 0.05) when comparing groups I and II.

Download (216KB)

Copyright (c) 2024 Levkovich M.A., Krukier I.I., Avrutskaya V.V., Ermolova N.V., Kravchenko L.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).